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Adolescents have a proclivity for risk taking and novelty seeking which can lead to 
BZP use and this can be damaging to the maturing brain. BZP is commonly consumed within 
party pills alongside TFMPP for its amphetamine like qualities and has the potential to be 
addictive. Therefore, it is important to study long term effects of BZP of which anxiety has 
been previously shown. The aim of this study was to investigate long term effects of BZP on 
anxiety and memory and to determine if attenuation by environmental enrichment is possible 
(because enrichment has demonstrated this with other drugs). 120 PVG/c rats of equal sex were 
housed in either enriched or standard caging and exposed to either saline, 10mg/kg or 20mg/kg 
BZP PND 41. They were then tested in a Y maze, elevated plus maze, light dark box and open 
field after PND 60 and PND 100 with two days in between each test. The results of this study 
showed BZP may affect memory but not after PND 100, anxiety may also be present depending 
on the apparatus used and sex of the animal, however results were conflicting. Lastly 
enrichment showed some memory enhancing capabilities and anxiolytic properties which 
further varied across apparatus. In conclusion BZP may decrease memory and increase anxiety 
over time but due to conflicting results needs further investigation. Similarly, although 
enrichment improved memory performance and decreased anxiety for some measures it also 












1.1 General Introduction 
Adolescence is a period when risk-taking and novelty-seeking is a common occurrence 
(Casey, Getz, & Galvan, 2008). Although this is adaptive while teenager’s transition from 
childhood till adulthood, it can also lead to partaking in drug use (Winters & Arria, 2011).. 
This proclivity to seek out these exciting experiences is due to changing brain structures, 
neurotransmitters, peer relationships and the strong effect of rewards at this stage of 
development (Winters & Arria, 2011) .These cause teenagers to be vulnerable to drug taking 
and can also lead to regular drug use. The changing brain additionally makes it vulnerable to 
any drug effects that might occur and theories of neuronal imprinting indicate these changes 
may not be apparent behaviourally until adulthood (Andersen & Navalta, 2004). 
A drug that is commonly used by young people is 1-benzylpiperazine (BZP) which is 
most often consumed in the form of party pills alongside TFMPP. This drug affects 
neurotransmitters such as dopamine and 5HT and is initially absorbed by the liver (Antia, Lee, 
Kydd, Tingle, & Russell, 2009; Staack, Fritschi, & Maurer, 2002). Furthermore, it travels 
through dopaminergic pathways within the brain and activates similar areas to amphetamines 
(Bava & Tapert, 2010). In the short term, it can produce positive feelings such as euphoria, 
however it can also produce negative effects like nausea (https://www.drugfoundation.org.nz). 
Research has additionally shown that alongside similar properties to amphetamines it may also 
have an abuse potential similar to methamphetamine (Baumann et al., 2004). This suggests that 
if teenagers use BZP there is a possibility that they could use it regularly. If this drug is used 
frequently long term effects such as anxiety may become pronounced (Aitchison, 2015). 
To reduce this anxiety and other effects that may occur such as memory problems, it is 
important to find ways to ameliorate BZP effects. Environmental enrichment which involves 





ameliorate memory impairments of other drugs(Simpson & Kelly, 2011; Townsend, 1998). 
Therefore, it is important to see if this experimental manipulation could reduce memory or 
anxiety effects of long term BZP use. 
Since anxiety is a problem experienced predominantly by women it is also important to 
include both sexes when investigating BZP effects and efforts to reduce them (Donner & 
Lowry, 2013) . Furthermore, although many studies don’t include female animals, without 
including both sexes important sex-related effects may be obscured and results may not 
translate from animals to humans (Kokras & Dalla, 2014). 
Lastly the aim of this experiment was to determine if BZP influences anxiety and 
memory in the long term when taken in adolescence. Environmental enrichment was also 
investigated as a possible method of ameliorating long term effects. 
1.2 Adolescent Development and Brain Vulnerability 
When considering ways of attenuating memory impairments or anxiogenic effects of 
BZP caused by use in adolescence it is important to demonstrate why BZP may be consumed 
during this age period and what effects drug taking can have on the vulnerable adolescent brain. 
Adolescence is a time when teenagers exhibit more risk taking and seek novel experiences. 
During this developmental period experimentation can begin with addictive drugs and patterns 
of long term drug abuse can emerge (Casey et al., 2008).  
When 11 or 12 years old, synaptic pruning begins in the brain. This involves the 
elimination of synaptic connections that are infrequently used and the strengthening of those 
used a lot (Giedd, 2004).  This process begins at the back of the brain within the limbic system 
and later moves forward to the front of the brain within the prefrontal cortex (Gogtay et al., 
2004; E. Meririnne, M. Kajos, A. Kankaanpaa, & T. Seppala, 2006). The slower maturation of 
the prefrontal cortex, which helps to make informed decisions and regulate emotions may lead 





brain has not yet developed enough to enable appropriate decisions to be made about these 
behaviours (Lubman & Yücel, 2008). Furthermore, elevated activity in emotional processing 
areas of the brain begins can consequently lead to reactions that are affected predominantly by 
emotional context (Hare et al., 2008). Therefore, when faced with highly emotional situations 
or peer pressure, adolescents may be likely to perform risk-taking behaviours based on 
momentary feelings  (Knowlton et al., 2010). Although this risk-taking can be adaptive as 
teenagers struggle to achieve independence from their parents, it can also lead to the 
consumption drugs such as BZP (Winters & Arria, 2011).  
Risk-taking and novelty- seeking can lead from drug experimentation to drug abuse, 
due to many factors. If peers are deviant, the home environment is unstable or if predisposing 
genetic factors are present, drug taking is increasingly likely to occur and could lead to drug 
abuse (Winters & Arria, 2011). Additionally, the earlier experimentation occurs the higher the 
likelihood that a substance use disorder will develop later in life (Winters & Arria, 2011).  
Furthermore, the strength that a reward such as drug consumption has for adolescents is 
different from adults (Bava & Tapert, 2010).  This means teenagers have a higher proclivity to 
try drugs due to the intensity of the reward anticipated (Galvan, 2010).  This is seen in 
functional magnetic resonance imaging, where greater striatal activation has been shown in 
adolescents in anticipation of a reward and with the reception of a reward (Galvan, 2010; Van 
Leijenhorst et al., 2010). Furthermore, due to the prefrontal cortex still developing adolescents 
have a reduced ability to assess potential outcomes of rewards e.g. using drugs for the euphoria 
experienced without considering effects on the brain or potential additive risks (Bava & Tapert, 
2010).  Dopamine release during these rewarding events can further result in a cycle of 
reinforced behaviour (Bava & Tapert, 2010). This means that when drugs are consumed 
dopamine is released in reward pathways producing a positive feeling, which causes the 





such as BZP the dopamine release they get from the drug could lead to seeking BZP again and 
possibly repeated drug use.  
Furthermore, during this stage of brain development, changes in dopamine also play a 
significant role in maturation. Within the prefrontal cortex, dopaminergic connections increase 
to other parts of the brain allowing faster dopamine facilitation between back, front and middle 
areas of the brain (Tunbridge et al., 2007). It has also been suggested dopamine receptor 
densities increase during adolescence and D1 and D2 densities start to peak in the striatum 
(Wahlstrom, White, & Luciana, 2010)  These changes in dopamine as well as other 
neurotransmitters (such as 5HT) occur in synchrony with changes in brain morphology and 
therefore can affect future behaviour, cognitions and other psychological processes (Paus, 
Giedd, & Keshavan, 2008). This is important for adolescents taking BZP party pills as this drug 
also affects the dopaminergic system and, as the brain is still developing, it is vulnerable to 
BZP effects. 
Lastly, neuronal imprinting posits that drug exposure effects may be delayed and are 
only shown in adulthood meaning that some effects last longer than those produced by acute 
treatment with the drug (Andersen & Navalta, 2004). Low doses of stimulants other than BZP 
have shown an in increase depressive and anxious symptoms later in life (Bolaños, Barrot, 
Berton, Wallace-Black, & Nestler, 2003; Carlezon, Mague, & Andersen, 2003). This supports 
neuronal imprinting theory and suggests similar reactions may be demonstrated with BZP.  
However, most of these studies involved subjects in childhood and not adolescence (Andersen 
& Navalta, 2004). Therefore, neuronal imprinting maintains that the young brain is vulnerable 
to changes after stimulant consumption, but that these effects will not be seen till adulthood. 
In conclusion, changing rates of maturation in different areas of the brain and teenagers’ 
high sensitivity to rewards can cause them to seek out novel experiences and perform risk 





homes and genetic factors may lead to drug-taking and substance abuse. Therefore, drugs may 
pose a risk of being abused by teenagers and thus could have long term effects on the brain that 
is undergoing significant structural and neurotransmitter changes. Neuronal imprinting 
suggests these effects may not be visible until adulthood. 
1.3 Benzylpiperazine 
Before we can consider the long-term effects of BZP on adolescents and how to prevent 
them it is important to consider BZP development, immediate effects and how it works within 
the body. BZP is a synthetic phenyl analogue of piperazine and in its freebase, form it is a pale 
yellow viscous liquid that reacts with air and light (Schep, Slaughter, Vale, Beasley, & Gee, 
2011). Originally this substance was developed as a treatment for intestinal roundworm and 
threadworm infections by Wellcome Research Laboratories (Schep et al., 2011). Later in the 
1970s it was investigated as a potential antidepressant since it was found to have similar effects 
to dexamphetamine in both subjective and objective reports. However, its potency was 
calculated to be only one tenth of that for dexamphetamine (Schep et al., 2011). It was later 
determined that BZP could be prone to abuse when administered to former addicts and 
consequently research into its antidepressant properties diminished (Campbell, Cline, Evans, 
Lloyd, & Peck, 1973). 
In recent years, it has been used recreationally in designer party pills (usually in 
combination with trifluoromethylphenylpiperazine/ TFMPP) due to its amphetamine like 
effects. There has also been some suggestion that BZP is as a safer alternative to 
methamphetamine (Wilkins, Sweetsur, & Parker, 2014). BZP was considered so safe that it 
was legal to purchase party pills containing BZP at any age in New Zealand until 2005, after 
which it was restricted to people 18 years and over (Wilkins et al., 2014). After 2008 BZP-





making it illegal to manufacture, import, export, supply, sell or consume (Cohen & Butler, 
2011). 
When investigating the short-term effects of BZP, it has been suggested that acute 
effects of BZP can be felt approximately 60 minutes after ingestion (Lin, Bangs, Lee, Kydd, & 
Russell, 2009). These effects can include a rise in blood pressure and heart rate which is caused 
by the additional increase in noradrenaline produced after BZP is consumed (Lin et al., 2009; 
Lin, Jan, Lee, et al., 2011; Schep et al., 2011). In humans, euphoria is commonly experienced 
as well as dysphoria once the drug effect begins to wear off (Lin et al., 2009; Lin, Jan, Kydd, 
& Russell, 2011). A decrease in fatigue has further been shown causing participants to stay 
awake for extended periods (Lin et al., 2009; Lin, Jan, Kydd, et al., 2011). Hunger can 
additionally be supressed, which resembles amphetamines that have been used as appetite 
suppressants (Kuo, 2005; Lin et al., 2009). Lastly, other effects can include increased energy 
and alertness, dehydration, stress, lack of emotional control, headaches (especially in 
combination with alcohol), nausea, hallucinations and in some cases convulsions 
(https://www.drugfoundation.org.nz). Therefore, varying positive and negative effects are 
witnessed acutely after BZP use. 
After ingestion BZP is rapidly absorbed and then metabolised in the liver, with the main 
pathways including hydroxylation and N-dealkylation (Antia et al., 2009; Staack et al., 2002). 
Within the brain, one of major effects is to increase neuronal dopaminergic transmission 
(Staack, Fritschi, & Maurer, 2002). Like amphetamines, it is thought to release dopamine and 
inhibit dopamine reuptake as well as postsynaptic receptor activity (Oberlander, Euvrard, 
Dumont, & Boissier, 1979). In vivo BZP has shown an increase both dopamine and serotonin 
(5HT) activity similarly (E. Meririnne et al., 2006). As with many other drugs of abuse, this 
increase in dopamine is thought to underlie the rewarding properties of BZP (E. Meririnne et 





may act like MDMA (Baumann et al., 2004).  Additionally, in vitro dopamine response is 
mediated by dopamine transporters. However, a similar mechanism does not seem to 
characterise the effect of the drug on 5HT (Baumann et al., 2004). This result has also been 
seen with methamphetamine suggesting that BZP may work in a similar fashion to this drug 
(Baumann et al., 2004).  Therefore, the mechanism by which BZP operates is similar to 
amphetamines and involves both dopamine and 5HT which indicates it has a similar addictive 
potential. 
1.4 Addictive Potential of BZP and Long Term Effects  
Before considering how any long-term adverse effects of BZP might be attenuated, it 
must first be demonstrated if people will be likely to take BZP regularly and if there are indeed 
any long-term effects of concern.  Similarities in mechanisms of action between BZP and 
amphetamines suggest that BZP may have a similar dependence potential to these drugs. 
Similarities in the behavioural effects of recognised addictive stimulants and BZP also suggest 
that it may have some addictive potential. Fantegrossi, Winger, Woods, Woolverton, and Coop 
(2005) have demonstrated this with rhesus monkeys that self-administered two different BZP 
doses at rates just as high and higher than the baseline dose of cocaine. Additionally, subjects 
responded strongly to saline several hours after they self-administered BZP (Fantegrossi et al., 
2005). The high self-administration responses with cocaine and the high responding after BZP 
was replaced with saline several hours later suggest that BZP was rewarding enough for 
monkeys to keep using it thereby suggesting an addictive potential. In another study by  
Brennan et al. (2007) lever responses previously maintained by cocaine continued to occur 
after the drug was replaced with BZP. BZP also showed high levels of responding on a drug 
lever in rats that had not previously been exposed to drugs.  Furthermore, the time taken for 





similarities between BZP and cocaine in self-administration and in behavioural effects also 
supported the premise that BZP has addictive potential. 
Similar addictive potential has been shown in studies with methamphetamine and BZP.  
This has been shown in cross sensitisation in which chronic BZP administration leads to 
sensitisation to methamphetamine (Brennan, Johnstone, Fitzmaurice, Lea, & Schenk, 2007). 
Herbert and Hughes (2009) have further demonstrated that behavioural effects in an open field, 
light dark box and responsiveness to change Y maze were similar between BZP and 
methamphetamine. Therefore, due to its similar mechanisms of action, behavioural effects and 
cross sensitisation to amphetamines, BZP may have considerable addictive potential.  Because 
of these characteristics, it is important determine any long-term effects of this drug especially 
as it is commonly used by adolescents.  
Although there is limited research on the long-term effects of BZP use, some studies 
have indicated that anxiety may result from its repeated use during adolescence. This was 
highlighted in a study by Aitchison and  Hughes, (2006) in which BZP was administered to 
rats for 10 days at the age equivalent of human adolescence. The results of their study showed 
that rats demonstrated higher anxiety than animals not given BZP ( Aitchison & Hughes, 2006). 
Other studies in which BZP was given to adolescent rats have also demonstrated that anxiety 
is found later when rats reach adulthood (Aitchison, 2015).   
In conclusion, if BZP is used during adolescence it has the potential to become 
addictive. This is evident from the research described in the above section.  Consequently, if 
this drug is addictive it is important to investigate the possibility of any adverse long-term 
effects it may have. Although there is not much research supporting this possibility, past studies 
have nevertheless revealed that BZP taken regularly during adolescence can lead to higher 
anxiety in adulthood. Therefore, attempts to attenuate such anxiety (or any other adverse long-





1.5 Environmental Enrichment 
To modify long term effects of BZP such as anxiety it’s important to consider 
environmental enrichment. Environmental enrichment is the process of exposing laboratory 
animals to social or physical stimulation that is greater than they would get in standard caging 
(Rosenzweig & Bennett, 1996). Physical enrichment involves modifications of the cage that 
an animal is housed in and can include means for enabling exercise, play and exploration such 
as the provision of plastic tunnels, wooden objects to bite, swings, ropes, balls, wheels, ramps 
and other similar sized toys (Simpson & Kelly, 2011; Townsend, 1998).     
Enrichment can lead to significant changes within the brain. In some studies, 
environmentally enriched rats have shown improved expression of the 5HT1 receptor in the 
hippocampus and frontal cortex (Brenes, Rodríguez, & Fornaguera, 2008; Rasmuson et al., 
1998). In the hippocampus of adult rats, environmental enrichment has also been found to 
increase neurogenesis, which is the increased generation of neural cells within the brain (Lu et 
al., 2003; Van Praag, Kempermann, & Gage, 2000). Other structural changes that have been 
associated with environmental enrichment include improved brain plasticity (Rosenzweig & 
Bennett, 1996), an increase in dendritic growth (Leggio et al., 2005), heavier brain weight 
(Bennett, Rosenzweig, & Diamond, 1969), increased cortical thickness and  synapse formation 
(Rosenzweig & Bennett, 1996).  
Environmental enrichment can also have effects on neurotransmitters such as dopamine 
and 5HT which are both implicated in BZP use. Some studies have shown that after 12 weeks 
in environmentally enriched housing, D1 density in the prefrontal cortex was reduced 
compared to controls (Del Arco et al., 2007). In addition, dopamine uptake, has been shown to 
decrease in this type of housing (Jun Zhu, Apparsundaram, Bardo, & Dwoskin, 2005; J. Zhu, 
Green, Bardo, & Dwoskin, 2004). Therefore, environmental enrichment can lead to structural 





The importance of environmental enrichment for changing behaviour was first seen in 
the 1940s when Donald Hebb took laboratory rats home where they were free to roam as house 
pets (Simpson & Kelly, 2011). This led to better learning and problem solving abilities than 
those housed in standard caging (Simpson & Kelly, 2011).  For non-drug induced animals 
enrichment has been shown to increase spatial memory in both the water maze and T maze. In 
the water maze, enriched animals remembered the ladder’s location better than controls housed 
in standard housing(C, D, & J, 1989; Wainwright, Lévesque, Krempulec, Bulman-Fleming, & 
McCutcheon, 1993). In the T maze, enriched animals also performed better on spatial memory 
tasks than non-enriched animals (Walsh & Cummins, 1975). In an experiment by Sampedro-
Piquero, Zancada-Menendez, Begega, Rubio, and Arias (2013), general anxiety was also 
shown to be reduced by environmental enrichment. The showed that enrichment caused lower 
anxiety in the elevated zero maze reflected in shorter latencies to enter open areas and increased 
time spent in these areas.  Improved spatial memory was also seen in the radial arm water maze 
(Sampedro-Piquero et al., 2013).  These results support the view that environmental enrichment 
can affect both anxiety and spatial memory in animal subjects. 
Lastly there have been no experiments reported in which environmental enrichment 
was used to counteract long term effects of BZP consumed in adolescence on later anxiety, or 
other adverse effects that might occur. There have however, been studies which have shown 
that enrichment can attenuate effects of other drugs ( Hughes, 2013). In an experiment 
conducted by  Hughes and Otto (2013), rats were treated with scopolamine and then later tested 
in an open field, y maze and light-dark box. Although scopolamine had an anxiogenic effect, 
this was attenuated in animals that were housed in enriched environments.  In another 
experiment by Schneider, Turczak, and Przewłocki (2006) male rats exposed to valproic acid 
during gestation developed lower levels of subsequent anxiety when housed in enriched cages 





anxiogenic effect of the drug. Results further showed that animals housed in enriched housing 
had lower anxiety than those in standard caging, suggesting enrichment attenuated anxiety. 
Therefore, since enrichment has been shown to attenuate the adverse effects of other drugs, it 
is possible it might also attenuate any adverse effects of BZP.  
In conclusion, environmental enrichment is the process of providing housing that 
contains elements (such as “toys”) that enable rats to explore and manipulate their environment.  
Such enrichment can also have effects on brain structures such as the hippocampus and the pre-
frontal cortex, and can increase neurogenesis as well as brain plasticity. Changes in 
neurotransmitters such as dopamine and 5HT are also found when animals are housed in 
enriched environments. Furthermore, for both drug-treated and non-drug-exposed animals, 
environmental enrichment has been shown to improve memory and reduce anxiety as well as 
counteracting other adverse drug effects. Therefore, it is important to see if environmental 
enrichment can ameliorate any adverse effects of BZP. 
1.6 Sex Differences 
When considering long-term effects of BZP consumed during adolescence and possible 
attenuation by enrichment, it is important to determine if results can vary between sexes. This 
is especially useful since most animal models are intended to represent psychiatric disorders 
experienced by humans which can often be sex-dependent (Kokras & Dalla, 2014; Overstreet 
et al., 2003). It is also important because of sex differences in human anxiety, and because 
higher anxiety can be a long-term consequence of BZP use. Furthermore, lifetime prevalence 
of anxiety disorders in females is 60% higher than in males (Donner & Lowry, 2013; Wittchen 
et al., 2011). Similar onset course, severity and response to treatment of anxiety can also vary 
significantly for women (Donner & Lowry, 2013). However, despite such sex differences, most 






 Reasons why male rats are mainly used in research include the mistaken belief that 
female non-sexual behaviour is identical to that of males, but is more variable (Kokras & Dalla, 
2014). Another reason for the use of males exclusively is the fact that female animals 
experience an oestrus cycle with accompanying hormonal changes. It is believed that this cycle 
could accordingly interfere with behavioural testing procedures (Jill B. Becker et al., 2005). 
These concerns about confounding outcomes are not completely unfounded. When female rats 
are in their oestrous cycle and exposed to amphetamine locomotion is increased (J. B. Becker 
& Cha, 1989) and when rats are administered cocaine they are more likely to be sensitive to 
effects of this drugs effect during this cycle (Festa & Quinones-Jenab, 2004; Lacy, Strickland, 
Feinstein, Robinson, & Smith, 2016). However, female’s animals are not the only ones to be 
affected by hormones that could influence results. After consumption of ethanol aggression 
was mediated by testosterone in male mice (DeBold & Miczek, 1985), and social investigation 
has been shown to increase when caffeine is consumed by male rats (Holloway & Thor, 1984). 
Therefore, although concerns about using females in experiments can be justified in certain 
situations, males may also be subject to hormonal influences. 
Despite aforementioned arguments against using females in experimental procedures 
there are reasons for their inclusion. This is because inclusion of both sexes can enhance animal 
model validity and assist in sex-related diagnosis, prevention and treatment of mental health 
disorders ( Hughes, 2007). There is also the possibility that without the use of both sexes, 
important information based on sex will not be available (Blanchard, Griebel, & Blanchard, 
1995). Additionally, without sex comparisons, animal research may not accurately reflect 
human responses to drugs or psychiatric illnesses ( Hughes, 2007). This is because male-only 
research indicates that results may only apply to human men, and not to women (Kokras & 
Dalla, 2014). Therefore, it is clearly important to include both males and females in animal as 





In conclusion, a major long-term effect of BZP previously reported is increased anxiety. 
Since anxiety is commonly experienced by women, it is important that animal research reflects 
this. However, due to due to beliefs about close similarities between male and female behaviour 
and possible confounding effects of the female oestrus cycle in rats, only males are used in a 
majority of studies. Without the inclusion of females in psychopharmacological studies 
important information may be missed and results of studies may not accurately carry over to 
human females as well as males. Therefore, it is important to include both sexes when 
investigating relationships between the effects of drugs, such as BZP, and enrichment as both 






2.0 Aim and Hypothesis 
The aim of the research presented in this thesis was to determine if there were any long-
term effects on anxiety and memory after repeatedly exposing male and female adolescent rats 
to BZP. It was predicted from the results of earlier research (described above) that adolescent 
BZP would increase later anxiety.  Due to the comparative lack of similar research into effects 
on memory, the possibility of BZP-associated changes in this process was also investigated. 
The major aim of the research was to see if environmental enrichment could ameliorate any 
long-term effects of BZP. It was predicted that this enrichment would reduce any BZP-induced 
increases in anxiety, or any memory impairments that might also occur.  The latter prediction 



















The subjects in this experiment were 120 PVG/c hooded rats, that were breed at the 
University of Canterbury Psychology Animal Facility. Half of the rats in this experiment were 
male and the other half were female. This was arranged so that assessment of any sex 
differences in responsiveness to BZP or environmental enrichment could be analysed. 
When the pups were 30 days old they were weaned and housed in an experiment room 
on a 12-hr light cycle from 8am onwards. Animals lived inside plastic cages with free access 
to water and food (rat pellets). These cages were 470 x 280 x 230 mm and the animals were 
housed in groups of 2 to 4 for the rest of the experiment. Half of the rats used in this experiment 
were randomly allocated to standard cages and the rest were in enriched cages that contained 
several toys. These toys included a selection of randomly chosen jars, metal lids, marbles, 
boxes, household utensils and tunnels. The objects were there to encourage the rats to explore 
by enabling them to manipulate, climb over or into, and generally investigate the toys providing 
perceptual enrichment. They were also replaced weekly with new randomly chosen objects to 
novelise their surroundings. Standard caging was the same as the enriched caging except for 
the toys which were only provided to the enriched group. This was arranged so that the impact 
of environment in BZP responsiveness could be assessed. All the subjects and procedures were 
approved by the Animal Ethics Committee of the University of Canterbury (see Appendix A). 
Subjects were randomly allocated into saline and two different BZP groups with equal 
numbers in each caging condition. Then at PND 41 animals were given intraperitoneal 
injections with saline or BZP depending on what they were randomly assigned to, over 10 days. 
The age of drug exposure was selected to represent the equivalent age of adolescence in humans 





interval between each test and the order of testing varied for individual rats. Then, from 100- 
112 days after birth, all behavioural testing was repeated. These time periods were chosen to 
represent different stages of early and middle adulthood and therefore measure long term 
effects of BZP (Andersen, 2003).  
3.2 Drug Dose 
1-Benzylpiperazine was purchased from Sigma-Aldrich based in Missouri USA. For 
the 10mg/kg solution 0.25ml of BZP was mixed with 25ml of 0.9% isotonic saline and for the 
20mg/kg dose 0.50ml of BZP was mixed with 25ml of saline. These doses were chosen to 
determine if strength of BZP showed dose effects and based on previous research where 
anxiolytic results were found with 10mg/kg dose ( Aitchison & Hughes, 2006) 
Subjects were intraperitoneally injected 1ml per kilogram based on their daily weights 
which were recorded over the dose treatment period. The same method was used when 
administering to the saline only group. Furthermore, intraperitoneal injection was used as a 
method of administration due to its accuracy and because it’s relatively easy to administer and 
learn (Coria-Avila, Pfaus, Ménard, Gavrila, & Ismail, 2007). 
3.3 Apparatus and Behavioural Procedures 
Each subject was tested in a responsiveness to change Y maze, elevated plus maze, light 
dark box and open field test in a dimly lit experiment room. There were two days between each 
apparatus and subjects were randomly assigned to start on different apparatus as a 
counterbalancing measure. Furthermore a 3 second timer was used with headphones so that 







3.4 Y Maze 
In the responsiveness to change Y maze whether the animals could remember which 
arm of the apparatus was novel was used as a measure of spatial memory, through novel 
observations, entries and transitions (Conrad, Galea, Kuroda, & McEwen, 1996). This maze 
was placed on a 70-cm table and had a stem with two arms coming out from the stem at a 120° 
angle.  Each of these two arms were 45 cm long, 10 cm wide and 14 cm high with a clear 
Perspex lid that covered the apparatus including the stem. Although the stem was 30 cm long 
it was cut through the middle by a wooden insert leaving a 15cm of the stem for the rats to be 
placed in. Furthermore, there were four metal inserts one painted white and the other three 
painted black which could be placed within the arm. The maze was lit from above with 
fluorescent lights.  
The Y maze procedure involved an acquisition trial where a white insert was placed in 
one arm and a black insert in the other. A rat was then placed in the stem of the maze and 
allowed to freely roam the maze for 5 minutes timed with a stop watch. After that trial, the rat 
was returned to its cage and the apparatus were cleaned with a 20% Paraquat blue solution. 
Both arms were then replaced with two black arms and the rat was put back into the stem of 
the maze for a retention trial. During this retention trial behaviours were recorded for 3 minutes 
and attention was paid to time spent in the arm that had changed from white to black (novel 
arm).  
Behaviours were recorded on testing sheets and entries of arms were only counted when 
subjects fully entered the arm with all paws. These behaviours included which arm (or the 
stem) rats were in, entries of the novel arm and total entries of both arms. This process was 







3.5 Elevated Plus Maze 
The elevated plus maze was chosen as a measure of anxiety because it represents a 
conflict between wanting to explore the novel environment and the animals fear of heights 
(Rodgers & Dalvi, 1997). This is because it has been proposed that animals that are anxious 
will decrease time spent in the open arm of the apparatus (Rodgers & Dalvi, 1997). The maze 
had four 100 cm long and 50 cm wide arms. These arms extended from a 15cm long and 15 
cm wide platform and these arms were 90° to each other. The open arms were facing each other 
and were 24 cm high on the ends and side walls which were constructed by Perspex. The closed 
arms had the same dimensions however they were made of painted black metal. The maze was 
lit by florescent lights and sat on a stand that was 1m high (a CCTV camera was also above the 
maze). 
The maze procedure involved placing an animal in the centre of the apparatus facing 
one of the closed arms. For five minutes the animal could freely roam the maze and number of 
entries into either the closed or open arms were recorded when all four feet were inside. 
Additionally, every three seconds the location of the subject was recorded on a testing sheet, 
which was seen through CCTV. The animal was then replaced in its cage and apparatus cleaned 
with the Paraquat solution to stop olfactory smells interfering with behaviour. 
3.6 Light Dark Box 
The light dark box measured anxiety based on the premise that for rats there is a conflict 
between wanting to explore the novel environment and fear of the brightly lit room (Ennaceur 
& Chazot, 2016). Therefore, if animals are anxious they will decrease time spent in the light 
area  and increase time taken to emerge into the light (Ennaceur & Chazot, 2016). The wooden 





and is 30 cm long, 25 cm high and 25 cm wide. This area is also illuminated from above with 
a fluorescent light and covered with a clear Perspex lid. The light area is separated from the 
dark area by a wooden wall that has an opening big enough for the rat to go between parts of 
the box. It also has an insert that blocks this opening when needed. The dark area is painted 
black and has the same dimensions as the light, however it has a wooden lid allowing blocking 
the light. 
The procedure for this apparatus involves placing the rat inside the dark component of 
the box for 30 seconds (measured using a stop watch) with the compartment slide in place. 
After this the slide is removed allowing the animal to freely move between compartments for 
5 minutes. A stopwatch was then used to time how long it took for the rat to emerge (all four 
feet) into the light for the first time. This was used to determine the emergence latency of the 
animals. Then for every three seconds which compartment the animal was in was recorded on 
a testing sheet using the CCTV from the camera above the box. Afterwards the rat was returned 
and the box cleaned before the next rat was used. 
3.7 Open Field 
The open field was the last apparatus used to measure anxiety responses and is based 
on the premise that rodents show an aversion to unknown environments that are open and 
brightly lit (Seibenhener & Wooten, 2015). The wooden open field was comprised of a black 
wooden floor and walls that was 60 cm in both width and length and 30 cm high.  There were 
also 16 numbered squares that were equally 15 cm long and wide with 4 across and 4 down. 
There was also a camera situated above the open field that allowed viewing of the subjects 
behaviour through CCTV.  
In the open field rats were initially placed in the centre of the apparatus then for 5 





square rats were in (ambulation was calculated by the number of transitions between squares) 
and whether they were engaging in walking, rearing on hind legs, grooming or were immobile. 
At the end of the 5 minutes the subject was placed back in their cage and the number of faecal 
boluses left in the apparatus were counted. Lastly the open field was cleaned before the next 
rat was placed inside.  
4.0 Results 
For each behavioural task a 3 x 2 x2 (Dose x Sex x Cage Condition) factorial ANOVA 
was used. The total number of rats was 120, with equal numbers in each condition (i.e. 60 
Male/60 Female; 60 Standard Housed/60 Enriched; 20 rats per dosage – control, 10mg/kg, 
20mg/kg). When appropriate, post hoc comparisons were performed with Scheffé tests. 
4.1 PND 60 Y Maze 
Table 1 and 2 show means (±SEMs), and results of ANOVAs for main effects for the 
three Y-maze measures (% Novel entries, % Novel observations and Total entries).  Results 
for significant dose main effects, plus two and three-way interactions are shown in Figures 1 
through 4. 
A BZP main effect for total entries was significant (see Table 1). Post hoc Scheffé tests 
showed that saline-treated subjects entered both arms of the Y maze significantly more often 
than 20mg/kg BZP subjects (see Figure 1). This did not occur with 10mg/kg BZP. 
Table 1: 60 days mean (S.E.M) percentage of novel entries, percentage of novel observations and total 
entries of both arms for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40) and results for F tests. 
BZP Dose 
60 Days 
Saline 10mg/kg 20mg/kg F 
(2, 108) 
P 
% Novel Entries 









8.68 (0.45)     
 
54.19(2.85) 















Figure 1: Main effects of dose in the total number of entries of both arms for control (n= 40 subjects), 
10mg/kg (n=40 subjects) and 20mg/kg (n=40 subjects). Standard error means are represented by error 
bars and * = significantly different from saline. 
As revealed by a significant dose x cage interaction (F (2,108) = 7.22, p = .001; see 
Figure 2) percent of entries into the novel arm with differing cage conditions depended on BZP 
dose. Those in enriched housing that received 10mg/kg of BZP entered the novel arm 
significantly more often than those in standard housing whereas for rats treated with 20mg/kg 
BZP, this relationship was reversed. Lastly 10mg/kg BZP subjects in standard caging made 
significantly fewer novel arm entries than those in the 20mg/kg dose group, this difference was 
not found between enriched BZP groups. Post hoc tests additionally showed that there was no 
difference in percentage of novel entries between standard and enriched rats in the saline dose 























Figure 2: Dose x Cage interaction in percentage of novel entries for the Control (n= 20 standard and 20 
enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). 
Standard error means are represented by error bars. Abc = groups with superscripts in common are 
significantly different. 
For percent of time spent in the novel arm, there was a significant three-way interaction 
(F (2, 108) = 6.54, p = .002; see Figure 3). This is best accounted for by the response being 
decreased by the higher dose of BZP for females from standard cages, and increased by both 
doses for females from enriched cages.  Males from either type of cage were not significantly 
affected by the drug. In addition, female enriched subjects in both BZP dose groups increased 
time in the novel arm of the apparatus than their counterparts in standard caging, and standard 
females in the saline dose group were observed significantly more often in the novel arm than 

































Figure 3:  Dose x Sex x Cage interaction in the percentage of observation in the novel arm for control (n= 
20 males half standard, half enriched and 20 females half standard and half enriched), 10mg/kg 
(distributed the same as control) and 20mg/kg (distributed the same way as the other two doses). 
Standard error means are represented by error bars. * = significantly different from saline and Abc = 
groups with superscripts in common are significantly different. 
Within cage and sex conditions, rats housed in standard cages exhibited more total arm 
entries than enriched subjects (Cage Condition Main Effect for Total entries; Table 2) but no 
housing effects were observed for either entries to, or time observed in the novel arm. 
Furthermore, female rats were observed less often in the novel arm than males (Sex Main Effect 
for % Novel Observations; Table 2), but exhibited more total arm entries (Sex Main Effect for 
Total Entries; Table 2). 
Lastly total arm entries varied by sex and housing (Sex x Cage Condition Interaction: 
F (1, 108) = 4.27, p = .041; Figure 4). Enriched males had significantly fewer total entries than 
enriched females and standard males. Therefore, enrichment effected male entries between 
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Table 2: 60 days mean (S.E.M) percentage of novel entries, percentage of novel observations and total 




Standard  Enriched F 
(1, 108) 
P 
% Novel Entries 
% Novel Observation 



















Male Female F 
(1, 108) 
P 
% Novel Entries 





















Figure 4: Sex x Cage interactions in the total number of entries of both arms of the maze for male (n= 30 
standard and 30 enriched) and female (n= 30 standard and 30 enriched). Standard error means are 
represented by error bars. * Abc = groups with superscripts in common are significantly different. 
 
4.2 PND 100 Y Maze 
Table 3 provides mean (±SEM), and ANOVA main effects of dose, cage and sex on the 
three Y-maze measures (% Novel entries, % Novel observations and Total entries). There were 

























Dose main effects found at PND 60 were not present after PND 100 days and there 
were no longer any cage differences in total number of entries. In addition, there were no further 
sex differences in the observations of subjects in the novel arm. However, female rats continued 
to enter both arms of the Y maze more often than male subjects (Sex Main Effect for Total 
Entries; Table 3).  
Table 3: 100 days mean (S.E.M) percentage of novel entries, percentage of novel observations and total 
entries of both arms for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40), standard cages (n=60), 
enriched cages (n=60), male (n =60) and female (n=60) and results for F tests. 
BZP Dose 
100 Days 
Saline 10mg/kg 20mg/kg F 
(2, 108) 
P 
% Novel Entries 









7.1 (0.41)     
 
60.28(2.33) 












Standard  Enriched F 
(1, 108) 
P 
% Entries of Novel Arm 
% Observations in Novel Arm 



















Male Female F 
(1, 108) 
P 
% Entries of Novel Arm 
% Observations in Novel Arm 



















4.3 PND 60 Elevated Plus Maze 
Tables 4 and 5 provides means (±SEMs), and ANOVA main effects for three elevated 
plus maze measures (%Open Arm entries, %Open Arm observations and Closed entries). 
Significant interactions are shown in Figures 5 and 6. 
All dose groups had an equal percentage of open arm entries and observations, as well 
as an equal number of closed arm entries. However, although there were no main effects of 





depended on BZP dose (Dose x Cage Interaction: F (2,108) = 3.4, p = .037; see Figure 5). 
Saline-treated subjects and those in the 20mg/kg BZP group significantly increased time in the 
open arm of the elevated plus maze when housed in enriched environments. The 10mg/kg BZP 
dose group didn’t show a difference between caging conditions. Time spent in the open arm 
was similar across drug groups and therefore no interactions was found between dose groups.  
Table 4: 60 days mean (S.E.M) percent of open arm entries, percent of open arm observations and closed 
arm entries for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40) and results for F tests. 
BZP Dose 
100 Days 
Saline 10mg/kg 20mg/kg F 
(2, 108) 
P 
% Open Arm Entries 
% Open Arm Observations 








9.52 (0.32)     
 
50.79(1.41) 












Figure 5: Dose x Cage interaction in the percentage of open arm observations for the control (n= 20 
standard and 20 enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 
20 enriched). Standard error means are represented by error bars and Abc= groups with superscripts in 
common are significantly different. 
Within cage and sex conditions subjects housed in enriched environments increased 
time spent in the open arm than those in standard caging (Cage Main Effect for % Open 
Observations; Table 5), but showed no difference in percentage of open arm entries or number 




































(Sex Main Effect for % Open Observations; Table 5), and the closed arm than males (Sex Main 
Effect for Closed Arm Entries; Table 5). Furthermore, closed arm entries varied by sex and 
housing (Sex x Cage Condition Interaction: F (1, 108) = 5.57, p = .020; Figure 6). Enriched 
males made significantly fewer closed arm entries than females and members of each sex 
entered the closed arms equally. There were no significant differences between cage 
conditions. 
Table 5: 60 days mean (S.E.M) percent of open entries, percent of open observations and closed entries 
for standard cages (n=60), enriched cages (n=60), male (n =60) and female (n=60) and results for F tests. 
Cage Condition 
 
Standard  Enriched F 
(1, 108) 
P 
% Open Arm Entries 
% Open Arm Observation 



















Male Female F 
(1, 108) 
P 
% Open Arm Entries 
% Open Arm Observation 



















Figure 6: Sex x Cage type interactions in the number of closed arm entries for male (n= 30 standard and 
30 enriched) and female (n= 30 standard and 30 enriched). Standard error means are represented by 


























4.4 PND 100 Elevated Plus Maze 
Table 6 and 7 provide means (±SEMs), and ANOVA main effects at PND 100 days for 
three elevated plus maze measures (% Open Arm entries, % Open Arm observations and 
Closed entries) and a significant interaction is demonstrated in Figure 7. 
 After 100 days, there were no main effects of dose (see Table 4).  However, 
observations in the open arm of the apparatus at differing doses of BZP depended on housing 
condition (Dose x Cage Interaction: F (2,108) =5.13 p = .007; see Figure 6) i.e., response was 
decreased by both doses for standard-caged subjects, but not for those from enriched cages. 
Contrary to results at PND 60, saline-treated subjects in enriched housing spent decreased time 
in the open arm than standard caged subjects. Additionally, 20mg/kg BZP subjects were no 
longer affected by the cage conditions.  
Table 6: 100 days mean (S.E.M) percent of open arm entries, percent of open arm observations and 
closed arm entries for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40), enriched (n= 60) and standard 
(n=60) and results for F tests. 
BZP Dose 
100 Days 
Saline 10mg/kg 20mg/kg F 
(2, 108) 
P 
% Open Arm Entries 
% Open Arm Observations 








7.2 (0.37)     
 
47.4(1.93) 
















Figure 7: Dose x Cage interaction in the percentage of open arm observations for the control (n= 20 
standard and 20 enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 
20 enriched). Standard error means are represented by error bars. * = significantly different from 
control and Abc= groups with superscripts in common are significantly different. 
Cage condition no longer affected open arm entries, time spent in the open arm or closed 
arm entries (see Table 7). Females continued to be observed more often in the open arm (Sex 
Main Effect for % Open Observations; Table 7), and in the closed arm than males (Sex Main 
Effect for Closed Arm Entries; Table 7). The sex x cage interaction was no longer significant. 
Table 7: 100 days mean (S.E.M) percentage of open arm entries, percentage of open arm observations 
and closed entries of both arms for standard cages (n=60), enriched cages (n=60), male (n =60) and female 
(n=60) and results for F tests. 
Cage Condition 
 
Standard  Enriched F 
(1, 108) 
P 
% Open Arm Entries 
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4.5 PND 60 Light Dark Box 
Table 8 and 9 show means (±SEMs), and results of ANOVAs for each main effect for 
the four light dark box measures (Emergence Latency, Light entries, Light Dark transitions and 
Light observations).  Results for significant two and three-way interactions are shown in 
Figures 8 through 12. 
There were no significant main effects of BZP dose on any light dark box measure (see 
Table 6). However, time taken to emerge into the light side of the apparatus at differing doses 
of BZP depended on housing (Dose x Cage Interaction: F (2,108) = 4.52, p = .013; see Figure 
8). This can be accounted for by the response being increased by both doses of BZP for enriched 
caged animals. Additionally, saline-treated subjects in enriched housing took significantly 
decreased time to emerge from the dark side of the apparatus than those in standard caging. 
There were no other significant differences. 
Table 8: 60 days mean (S.E.M) emergence latency, entries of light, transitions and observations in light 
for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40) and results for F tests. 
BZP Dose Saline 10mg/kg 20mg/kg F 
(2,108) 
P 
Emergence Latency 8.57(1.46) 9.93(0.99) 8.75(1.32) 0.37 .691 
Light Entries 9.9(0.28) 9.2(0.34) 9.6(0.36) 1.29 .281 
Transitions 19.42(0.55) 18.1(0.67) 18.8(0.72) 1.21 .303 







Figure 8: Dose x cage interaction in emergence latency for the control (n= 20 standard and 20 enriched), 
10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). Standard 
error means are represented by error bars. * = significantly different from saline and Abc= groups with 
superscripts in common are significantly different. 
 
Entries of subjects into the light side of the apparatus at varying doses of BZP was also 
dependant on housing (Dose x Cage Interaction: F (2,108) = 5.14, p = .007; see Figure 9). 
Within the enriched cage condition both BZP groups entered the light fewer times than saline 
treated animals. There were no similar effects seen within the standard caging groups. Saline 
subjects in enriched housing entered the light side of the apparatus more often than those in 
standard housing. This was reversed for 20mg/kg BZP subjects and there was no relationship 




































Figure 9: Dose x Cage interaction in entries of the light for the control (n= 20 standard and 20 enriched), 
10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). Standard 
error means are represented by error bars. * = significantly different from saline and Abc= groups with 
superscripts in common are significantly different. 
 
Transitions of the subjects between the light and dark side of the apparatus at varying 
doses of BZP was dependant on housing (Dose x Cage Interaction: F (2,108) = 5.55, p = .005; 
see Figure 9). Enriched saline subjects transitioned between both sides of the apparatus 
significantly more often than 20mg/kg BZP subjects. No similar differences were found within 
standard cages or between enriched controls and 10mg/kg BZP animals. Like the previous 
measure saline treated subjects had higher transitions when living in enriched conditions, this 
was the opposite for 20mg/kg BZP subjects. There was no difference between cages for 




























Figure 10: Dose x Cage interaction in transitions between the light and dark for the control (n= 20 
standard and 20 enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20) standard and 
20 enriched). Standard error means are represented by error bars. * = significantly different from saline 
and Abc= groups with superscripts in common are significantly different. 
 
For percent of time spent in the light, there was a significant three-way interaction (F 
(2, 108) = 4.95, p = .008; see Figure 11). This can be mainly accounted for by the response 
being decreased by the higher dose of BZP for females from enriched cages.  Enriched 20mg/kg 
BZP females were also observed significantly less often in the light side of the apparatus than 
either the saline-treated or the 10mg/kg BZP group. This effect of drug dose was not apparent 
for females in standard cages, or for males in either type of cage. Additionally, enriched 
housing led to increased observations in the light side of the apparatus for females treated with 






























Figure 11:  Dose x Sex x Cage interaction in emergence latency for control (n= 20 males half standard, 
half enriched and 20 females half standard and half enriched), 10mg/kg (distributed the same as control) 
and 20mg/kg (distributed the same way as the other two doses). Standard error means are represented by 
error bars. * = significantly different from saline and Abc = groups with superscripts in common are 
significantly different. 
 
The time spent in the light side of the apparatus was significantly higher for enriched 
than standard-caged animals (Cage Condition Main Effect for Light Observations; Table 9). 
Additionally, females entered the light more often (Sex Main Effect for Light Entries; Table 9) 
and had significantly a higher amount of transitions than males (Sex Main Effect for 
Transitions; Table 9). There were no other significant main effects found for responses 
recorded in this apparatus. Lastly, sex differences in emergence latency depended on housing 
(Sex x Cage Condition Interaction: F (1, 108) = 4.64, p = .033; Figure 12). Females took less 
time to emerge than males only when housed in standard caging. Standard-caged females also 






































Table :9 60 days mean (S.E.M) for emergence latency, entries of light, transitions and observations in 




Figure 12: Sex x Cage interactions in emergance latency for male (n= 30 standard and 30 enriched) and 
female (n= 30 standard and 30 enriched). Standard error means are represented by error bars and Abc= 
groups with superscripts in common are significantly different. 
 
4.6 PND 100 Light Dark Box 
Tables 10 and 11 provide means (±SEMs), and ANOVA main effects at PND 100 for 
the four light dark box measures (Emergence Latency, Light entries, Light Dark transitions and 
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There were no dose main effects present after PND 100 (see Table 10) and no 
interactions involving BZP dose for emergence time, or for observations in the light. However, 
entries into the light at varying doses of BZP were still affected by housing (Dose x Cage 
Interaction: F (2,108) = 3.19, p = .045; see Figure 13). Of the results obtained at PND 60, the 
only effect that remained the same as previously was that 20mg/kg BZP subjects still entered 
the light less often than saline-treated animals. A new effect that appeared after 100 days was 
that enriched 10mg/kg subjects exhibited more entries into the light side than standard-housed 
animals. 
Table 10: 100 days mean (S.E.M) emergence latency, entries of light, transitions and observations in light 
for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40) and results for F tests.  
BZP Dose Saline 10mg/kg 20mg/kg F 
(2,108) 
P 
Emergence Latency 12.65(3.23) 13.82(2.29) 17.25(4.75) 0.45 .641 
Entries of Light 6.90(0.26) 6.07 (0.29) 6.40(0.37) 2.04 .135 
Transitions 13.38(0.50) 11.77(0.67) 12.35(0.74) 1.95 .148 
Observations in Light 47.28(1.85) 45.10(2.46) 44.72(2.14) 1.35 .264 
 
 
Figure 13: Dose x Cage interaction in entries of the light for the control (n= 20 standard and 20 enriched), 
10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). Standard 
error means are represented by error bars. * = significantly different from saline and Abc= groups with 




























This measure was also affected at different doses of BZP by sex (Dose x Sex 
Interaction: F (2,108) = 3.69, p = .028; see Figure 14) at PND 100. This could be accounted 
for by the response being decreased by both doses of BZP for males, but not for females. 
Furthermore, females treated with 20mg/kg of BZP entered the light more often than their male 
counterparts 
 
Figure 14: Dose x Sex interaction in entries of the light for the control (n= 20 male and 20 female), 
10mg/kg (n= 20 male and 20 female) and 20mg/kg (n=20 male and 20 female). Standard error means are 
represented by error bars. * = significantly different from saline and Abc= groups with superscripts in 
common are significantly different. 
 
Light dark transitions continued to be affected by housing, but in a different way than 
before (Dose x Cage Interaction: F (2,108) = 3.12, p = .048; see Figure 15). After 100 days, 
none of the effects seen at PND 60 were present. However, a new effect was that 10mg/kg BZP 





























Figure 15: Dose x Cage interaction in light dark transitions for the control (n= 20 standard and 20 
enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). 
Standard error means are represented by error bars. Abc= groups with superscripts in common are 
significantly different. 
Unlike the earlier testing, light dark transitions at varying doses were also affected by 
sex (Dose x Sex Interaction: F (2,108) = 3.69, p = .028; see Figure 16). Both BZP male groups 
transitioned between the light and dark sides of the apparatus less often than saline-treated 
subjects. Post hoc testing also showed that 20mg/kg BZP females exhibited more light dark 
transitions than males. 
 
Figure 16: Dose x Sex interaction in light dark transitions for the control (n= 20 male and 20 female), 
10mg/kg (n= 20 male and 20 female) and 20mg/kg (n=20 male and 20 female). Standard error means are 
represented by error bars. * = significantly different from saline and Abc= groups with superscripts in 
























































For cage and sex conditions there was no longer a significant cage effect on light 
observations. Females continued to exhibit more entries of the light (Sex Main Effect for Light 
entries; Table 11) and transitions than males (Sex Main Effect for Transitions; Table 11). A 
new effect revealed after PND 100 was that females emerged into the light sooner than males. 
Lastly, as revealed in a significant sex x cage interaction (F (1, 108) = 4.27, p = .041), males 
from enriched cages increased time spent in the light side than those from standard cages (see 
Figure 17).  This did not occur for females.  
Table :11 100 days mean (S.E.M) for emergence latency, entries of light, transitions and observations in 
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Figure 17: Sex x Cage interaction in observations in the light for male (n= 30 standard and 30 enriched) 
and female (n= 30 standard and 30 enriched). Standard error means are represented by error bars and 
Abc= groups with superscripts in common are significantly different. 
 
4.7 PND 60 Open Field 
Tables 12 and 13 show means (±SEMs), and results of ANOVAs for each main effect 
for the eight open field measures (Ambulation, Centre occupancy, Corner occupancy, Walking, 
Rearing, Grooming, Immobility and Faecal boluses).  Results for significant dose main effects 
and significant two way interactions are shown in Figures 18 through 25. 
According to ANOVA results, there was a significant BZP main effect for grooming 
observations and faecal boluses eliminated in the apparatus (see Table 12). Post hoc Scheffé 
tests showed that 10mg/kg BZP subjects groomed themselves less often than rats from both the 
saline and the higher BZP dose groups (see Figure 18). Additionally, rats treated with both 
































Table 12: 60 days mean (S.E.M) ambulation, centre occupancy, corner occupancy, walking, rearing, 
grooming, immobility and faecal boluses for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40) and results 
for F tests. 
BZP Dose Saline 10mg/kg 20mg/kg F 
(2,108) 
P 
Ambulation 63.20(1.58) 60.25(2.04) 63.95(1.79) 1.52 .224 
Centre Occupancy 9.65(0.81) 9.32 (1.00) 10.07(1.3) 0.13 .879 
Corner Occupancy 42.58(1.64) 44.05(1.93) 42.12(1.33) 0.37 .691 
Walking 34.50(1.62) 34.95(1.62) 36.67(1.24) 0.70 .496 
Rearing 42.70(1.35) 36.55(2.47) 40.85(1.56) 0.94 .395 
Grooming 5.47(0.81) 2.8(0.41) 4.62(0.87) 3.73 .027 
Immobility 16.92(1.86) 22.00(1.15) 17.12(1.63) 2.79 .066 
Faecal Boluses 1.65(0.36) 0.85(0.26) 0.70(0.23) 3.40 .037 
 
  
Figure 18 and 19: Main effects of dose in grooming observations (18) and faecal boluses (19) for control 
(n= 40 subjects), 10mg/kg (n=40 subjects) and 20mg/kg (n=40). Standard error means are represented by 
error bars and * = significantly different from saline and Abc = groups with superscripts in common are 
significantly different. 
 
As shown by a significant dose x cage interaction (F (2,108) = 5.9, p = .003; see Figure 
20), time spent walking in the apparatus with different doses of BZP depended on the cage 
condition i.e., both doses increased the response for rats housed in enriched cages, but not for 













































Figure 20: Dose x Cage interaction in walking observations for the control (n= 20 standard and 20 
enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). 
Standard error means are represented by error bars. * = significantly different from saline and Abc= 
groups with superscripts in common are significantly different. 
The time the animals spent walking in the apparatus was also dependent on sex (Dose 
x Sex Interaction: F (2,108) = 4.16, p = .018; see Figure 21). Males in the higher BZP group 
were observed walking more often than both the saline and lower BZP dose group. Similar 
differences were not found for female subjects.  However, females treated with either saline or 
10mg/kg BZP females walked more often than males. 
 
Figure 21: Dose x Sex interaction in walking observations for the control (n= 20 male and 20 female), 
10mg/kg (n= 20 male and 20 female) and 20mg/kg (n=20 male and 20 female). Standard error means are 
represented by error bars. * = significantly different from saline and Abc= groups with superscripts in 





















































The effects of BZP on rearing activity were also dependent on housing (Dose x Cage 
Interaction: F (2,108) = 6.95, p = .001; see Figure 22). Standard caged subjects treated with 
10mg/kg BZP exhibited more rearing than saline-treated subjects.  This was not found for the 
20mg/kg BZP group. 10mg/kg BZP subjects in standard cages also exhibited more rearing than 
their enriched counterparts. This relationship was the opposite for saline-treated animals. In the 
20mg/kg BZP group both cage conditions spent an equal amount of time rearing.  
 
Figure 22: Dose x Cage interaction in rearing observations for the control (n= 20 standard and 20 
enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). 
Standard error means are represented by error bars. Abc= groups with superscripts in common are 
significantly different. 
The effects of BZP on immobility was dependant on sex (Dose x Sex Interaction: F 
(2,108) = 3.63, p = .029; see Figure 23). 10mg/kg males exhibited more immobility than both 
saline and 20mg/kg treated animals. Additionally, these males were immobile more often than 
their female counterparts. Females did not show any within-group differences, and no other 






























Figure 23: Dose x Sex interaction in immobility observations for the control (n= 20 male and 20 female), 
10mg/kg (n= 20 male and 20 female) and 20mg/kg (n=20 male and 20 female). Standard error means are 
represented by error bars. * = significantly different from saline and Abc= groups with superscripts in 
common are significantly different. 
 
Lastly there were no significant main effects of cage on any measure (see Table 13). 
However, there were significant sex differences for four of the measures i.e., males were in the 
centre of the apparatus and were immobile more often than females (see Table 13). Females 
engaged more often in locomotor behaviour than males, as reflected in the sex differences for 
ambulation and walking. However, as indicated by a significant sex x cage interaction for 
ambulation (F (1, 108) = 4.37, p = .039), enrichment significantly increased time spent moving 
around the open field for females (see Figure 24). A significant sex x cage interaction for faecal 
boluses showed that males defecated significantly more often than females only when housed 
in enriched cages (F (1, 108) = 9.91, p = .005; Figure 25). The interaction also revealed that 
































Table :13 60 days mean (S.E.M) for ambulation, centre occupancy, corner occupancy, walking, rearing, 
grooming, immobility and faecal boluses for standard cages (n=60), enriched cages (n=60), male (n =60) 
and female (n=60) and results for F tests 








































































  67.82 (1.22) 
  8.38 (0.56) 
  44.05 (1.43) 
  38.02 (1.13) 
  42.52 (1.08) 
  4.45 (0.71) 
  14.85 (1.15) 





  2.91 
  0.13 
  14.89 












Figure 24 and 25: Sex x Cage interactions for ambulation (24) and faecal boluses (25) for male (n= 30 
standard and 30 enriched) and female (n= 30 standard and 30 enriched). Standard error means are 
represented by error bars and Abc= groups with superscripts in common are significantly different. 
 
4.8 PND 100 Open Field 
Tables 14 and 15 show means (±SEMs), and results of ANOVAs for each main effect 

















































Rearing, Grooming, Immobility and Faecal boluses).  Results for significant two way 
interactions are shown in Figures 26 through 28. 
After 100 days, there were no longer any main effects of BZP dose on the time spent 
immobile or the number of faecal boluses left in the apparatus (see Table 14). However, cage 
condition still influenced walking for saline-treated subjects (Dose x Cage Interaction: F 
(2,108) = 3.74, p = .027; see Figure 26) namely, enriched saline-treated subjects continued to 
spend decreased time walking compared to standard.  
Table 14: 100 days mean (S.E.M) ambulation, centre occupancy, corner occupancy, walking, rearing, 
grooming, immobility and faecal boluses for saline (n=40), 10mg/kg (n=40) and 20mg/kg(n=40) and results 
for F tests 
BZP Dose Saline 10mg/kg 20mg/kg F 
(2,108) 
P 
Ambulation 54.28(2.46) 56.25(1.84) 54.97(2.21) 0.27 .767 
Centre Occupancy 8.40(0.67) 9.45 (0.93) 9.07(0.77) 0.47 .627 
Corner Occupancy 42.83(1.83) 42.42(1.52) 42.33(1.48) 0.80 .926 
Walking 34.97(1.65) 36.00(1.33) 36.20(1.74) 0.23 .795 
Rearing 41.00(1.61) 42.90(1.76) 39.45(1.90) 0.96 .387 
Grooming 1.23(0.19) 1.42(0.25) 1.92(0.25) 2.69 .072 
Immobility 22.67(2.39) 18.8(1.60) 22.35(2.77) 0.99 .374 
Faecal Boluses 1.33(0.34) 0.32(0.20) 1.05(0.80) 1.05 .354 
 
Figure 26: Dose x Cage interaction in walking observations for the control (n= 20 standard and 20 
enriched), 10mg/kg (n= 20 standard and 20 enriched) and 20mg/kg (n=20 standard and 20 enriched). 





























Effects of BZP on walking continued to be dependent on sex at PND 100 (Dose x Sex 
Interaction: F (2,108) = 3.29, p = .041; see Figure 27) namely, males in the 20mg/kg BZP 
group continued to walk more often than those treated with saline. Additionally, saline and 
10mg/kg BZP treated females continued to walk more often than males. There were no new 
interactions present after PND 100 and there was no longer a significant difference in walking 
between both BZP groups. 
 
Figure 27: Dose x Sex interaction in walking observations for the control (n= 20 male and 20 female), 
10mg/kg (n= 20 male and 20 female) and 20mg/kg (n=20 male and 20 female). Standard error means are 
represented by error bars. * = significantly different from saline and Abc= groups with superscripts in 
common are significantly different. 
Cage Condition continued to have no main effects on any of the open field measures 
(see Table 15). However, at this age, there were significant sex differences for all measures 
except two (see Table 15).  Males continued to have higher instances of immobility than 
females (Sex Main Effect for Immobility; Table 15).  A new effect was that males were 
observed in the corners of the apparatus and eliminated faecal boluses more often than females 
(see Table 15). Females continued to score higher on ambulation and walk more often than 
males (Table 15).  Contrary to results at PND 60, they also spent more time in the centre of the 
































Lastly sex and cage no longer interacted to affect ambulation and faecal boluses. 
However, they both contributed to walking observations at PND 100 (Dose x Cage Interaction: 
F (2,108) = 4.21, p = .042; see Figure 28). Males in both types of housing exhibited less time 
walking than females. There were no significant main effects of housing on any measure. 
Table :15 100 days mean (S.E.M) for ambulation, centre occupancy, corner occupancy, walking, 
rearing, grooming, immobility and faecal boluses for standard cages (n=60), enriched cages (n=60), male 
(n =60) and female (n=60) and results for F tests. 








































































  61.38 (1.62) 
  10.17 (0.57) 
  38.37 (0.90) 
  39.97 (1.14) 
  41.98 (1.27) 
  1.50 (0.18) 
  16.95 (1.64) 





  0.72 
  0.04 
  12.06 
















Figure 28: Sex x Cage interactions in walking observations for male (n= 30 standard and 30 enriched) 
and female (n= 30 standard and 30 enriched). Standard error means are represented by error bars and 
Abc= groups with superscripts in common are significantly different. 
 
5.0 Discussion 
In this study adolescent rats were treated with saline 10mg/kg or 20mg/kg of BZP. At 
PND 41 animals received intraperitoneal injections over 10 days representing adolescence. 
They were then tested in four different types of apparatus after PND 60 and PND 100.   
5.1 Summary of Main Results  
One of the main aims of this study was to discover whether BZP dose influenced spatial 
memory and if enrichment attenuated any of these effects if they did occur. After PND 60 
20mg/kg BZP subjects entered both arms of the Y maze less often than after saline. Although 
this doesn’t suggest memory deficiency it indicates that animals spent most of the time in the 
stem of the apparatus and were consequently, exhibiting higher anxiety ( Hughes, 2003). A 
similar result was not found for the 10mg/kg group which suggests that dose strength of BZP 




























Although there are no other main effects of drug dose the effect of BZP can be seen 
within interactions for entries and observations in the novel Y-maze arm. Standard-caged 
10mg/kg BZP subjects entered the novel arm less often than the higher BZP group, suggesting 
this group may have had poorer memory recall. However if BZP was the cause it would be 
expected that the 20mg/kg group would have showed a similar result. Therefore, this result 
could be explained by external factors not covered by this study. Results from observations in 
the novel arm do suggest that BZP may have influenced memory when sex is considered. 
Standard saline females were in the novel arm more often than the higher BZP group indicating 
that memory was impaired for this later group (Chambon, Wegener, Gravius, & Danysz, 2011). 
Conversely, enriched females treated with both BZP doses spent time in the novel arm more 
often than saline-treated subjects suggesting BZP improved spatial memory performance. 
However, because this was within the enriched group this may be explained by enrichment 
having a greater effect on memory for drug groups. Although this has not been previously 
shown it is important to consider. Additionally, the lack of results for males suggest that they 
may not be as susceptible as females to BZP’s effects on memory. 
Therefore after 60 days there are some suggestions that BZP may negatively affect 
memory consolidation in spatial memory tasks especially when exposed to higher doses of the 
drug and depending on sex. However, an increased amount of evidence is needed to support 
this due to conflicting results for the 10mg/kg group in entries of the novel arm. There are also 
results which suggest BZP may be anxiogenic which supports the hypothesis of this 
experiment. Furthermore, enrichment may have differing effects on memory in saline and BZP 
rats which needs to be considered further. After 100 days, any indications of BZP effecting 






 Although results regarding BZP effect on memory were mixed, at PND 60 enrichment 
per se did influence BZP-treated animals, which was demonstrated in novel arm entries and 
observations. Within the 10mg/kg BZP group enrichment increased the number of novel arm 
entries and increased novel observations of the 10mg/kg BZP female groups. This indicates 
that enrichment may have improved memory for these groups. Furthermore, enrichment 
increased time spent in the novel arm for the female 20mg/kg BZP group suggesting that 
previously mentioned memory impairment seen in standard caging of BZP on memory were 
improved with the enriched housing (Patel, 2012). Lastly, 20mg/kg BZP subjects decreased 
novel arm entries when housed in enriched housing and male subjects in this BZP group also 
decreased time in the novel arm when housed similarly. This suggest that BZP may have 
impaired memory for which arm was novel. However, because females showed an increase in 
time spent in the novel arm due to enrichment, this could be because males engage in less 
locomotion than females and therefore remained longer in the stem of the maze and decrease 
time spent investigating the novel area (Meunier & Fishcer, 1985). The strength of this 
locomotor effect could also be the reason why 20mg/kg BZP subjects were shown to enter the 
novel arm less often. None of these results were apparent at PND 100 further suggesting that 
effects of the drug on memory and enrichments increase in memory for females and decrease 
in memory for males did not last long term  
Therefore, enriched housing seems to have effect on memory performance caused by 
BZP in the Y Maze as predicted. However these results seemed to be reliant on the sex of the 
animal in some cases. Since not all the effects of enrichment seemed to be on BZP-related 
memory impairment, enrichment may also have attenuated other effects from standard caged 
animals such as anxiety. Lastly these effects seemed to diminish after an extended period. 
A second major aim of this study was to determine if anxiety effects of BZP seen 





effects. At PND 60 no effects of BZP on anxiety effects occurred in any of the elevated plus 
measures. However, at PND 100, anxiety effects were seen in the number of open-arm 
observations. As predicted both standard-caged BZP groups spent less time in the open arm of 
the apparatus indicating higher anxiety. Therefore, anxiety may only be shown behaviourally 
after an extended period. 
Enrichment did show an effect on both dose groups at PND 60, even though dose effects 
were not seen. As predicted for saline and the higher BZP dose group, enrichment increased 
time spent in the open arms suggesting that it had attenuated anxiety when housed in standard 
housing ( Hughes, 2003). This shows that environmental enrichment did have an impact on 
certain groups. Unfortunately, PND 100 enrichment did not attenuate BZP effects seen in 
standard cages. Therefore, it can’t be said that environmental enrichment attenuated BZP 
effects after 100 days in this model. 
The light dark apparatus was also used to assess this aim. At PND 60 there were no 
main effects of dose, but this does not mean that dose did not have an impact on subjects.  
Enriched housing was shown to increase anxiety as reflected in effects on emergence latency, 
light entries, transitions and light observations. This was seen in longer emergence latencies 
for both BZP groups, fewer entries of the light for both BZP groups and fewer light dark 
transitions or light observations for the higher BZP group compared to saline-treated animals. 
At PND 100 emergence latency and light observations no longer showed this adverse effect of 
BZP. However, entries of the light still showed that 20mg/kg BZP animals entered the light 
less often thus suggesting higher anxiety was still present for this group. This was further 
apparent for males for which both BZP groups showed higher anxiety than the saline group on 
this measure. Likewise, both BZP groups continued to show fewer transitions when only 





predisposition for decreased locomotor activity alongside BZPs potential to decrease this 
activity (Herbert & Hughes, 2009; Meunier & Fishcer, 1985). 
Therefore, BZP did affect anxiety at both ages supporting the hypothesis. However this 
was only for rats from enriched cages. The reason these dose differences were only seen for 
enriched-caged rats could have been due to enrichment enhancing anxiety effects. However it 
is difficult to suggest a reason for why this occurred. Furthermore, dose effects at PND 100 
been revealed only in males is also difficult to explain.  It may have been due to males 
ambulating less often than females (Elliott & Grunberg, 2005). Since both light entries and 
transitions represent ambulation as well as anxiety, males may have only showed an effect due 
to their proclivity to show less locomotion coupled with BZP effects on stereotyped behaviour 
(Herbert & Hughes, 2009; Meunier & Fishcer, 1985). Therefore, effects on anxiety are unlikely 
to persist into later adulthood unlike locomotor behaviour, which is not expected. 
Enrichment affected anxiety with saline by decreasing emergence latency, increasing 
light entries, increasing transitions and, for females, increasing light observations. However, 
for BZP it had the opposite effect for entries of the light and light dark transitions and was only 
significant for the higher BZP group. Although this could indicate that enrichment increased 
anxiety it could also be explained by enrichment decreasing locomotion. Enrichment decreases 
activity because of faster acclimation to surroundings. Because of this coupled with BZP-
related increases in stereotyped movement, effects on locomotion seem to be the best 
explanation for this result (Elliott & Grunberg, 2005; Herbert & Hughes, 2009). Enrichment 
did show an expected reduction of anxiety for the female 10mg/kg group as well as saline-
treated individuals. Unfortunately, because BZP-treated rats from standard cages did not show 
an adverse effect compared to saline, this decrease could have been in base-line anxiety and 
not BZP-related anxiety. At PND 100, effects of enrichment previously seen were not present 





Again, this increase can’t be attributed solely to BZP-induced anxiety. There is insufficient 
information as to why this was not seen for the other dose groups. 
Therefore, while enrichment did seem to show an effect on anxiety, this may not have 
been a specific reduction in BZP-related anxiety. Additionally, in some measures of the 
apparatus enrichment effects may be relevant to changes in locomotor behaviour caused by a 
combination of BZP and enrichment or sex and enrichment. 
The last type of apparatus used to investigate the aims of this study was the open field. 
There were no definitive anxiety effects attributed to BZP contrary to the hypothesis. For 
grooming, there were conflicting responses since 10mg/kg BZP produced fewer instances of 
grooming than either saline or 20mg/kg. This suggests this group was less anxious than the 
other two groups and it’s difficult to explain why this occurred. It may be due to factors beyond 
this study such as other stimuli, for example decreased noise or other experimenters that were 
present in the room with the other doses not being present at the time 10mg/kg BZP group was 
tested within the experimentation room. Contrary to grooming measures within male animals 
10mg/kg BZP increased immobility compared to other doses, which indicates increased 
anxiety. Due to these conflicting results for this group it is beyond the scope of this study to 
determine why these effects occurred. Furthermore, faecal boluses were reduced for both BZP 
groups contrary to what would be expected if BZP induced anxiety. This could be explained 
by BZP causing dehydration which means the body uses the fluid from the intestines making 
faecal boluses harder to pass (Thomas et al., 2008). Results from walking observations are also 
not best explained by anxiety. This is because the increased locomotor effects for both enriched 
BZP groups could be explained by BZP-increased energy, although this does not usually 
continue long past BZP administration (https://www.drugfoundation.org.nz). This is also 
supported by results which showed the higher BZP group had increased ambulation compared 





stayed the same were those for walking. This again suggested that locomotor effects may have 
persisted. However, no anxiety effects were seen at this age either  
Therefore, these results suggested that BZP did not induce anxiety unlike previous 
findings and effects on locomotion may have been the only outcomes. Additionally, influences 
outside of the scope of this experiment affected the 10mg/kg BZP in different ways that need 
further investigation. 
Lastly, saline-treated animals at PND 60 were affected by enrichment in walking and 
rearing as expected. It decreased walking a locomotion effect which is a common result of 
enrichment (Elliott & Grunberg, 2005). Furthermore, increases in rearing demonstrated a 
decrease in anxiety as rearing measures vertical exploration which can be inhibited by high 
anxiety (Walsh & Cummins, 1976). Rearing only affected the 10mg/kg BZP group by 
decreasing rearing. Again, this result is difficult to explain and since this is the same BZP group 
showing conflicting dose results more research is needed to determine why this occurred. 
Again at PND 100 the only measure to show a significant difference was walking. Enrichment 
again decreased locomotor effects for saline-treated individuals indicating enrichment still 
decreased locomotion, none of the other effects continued suggesting enrichment effects for 
other measures do not last long term. Therefore, within this apparatus enrichment did not show 
a significant effect on BZP anxiety, which is not what was predicted.  
In conclusion, the main aims of this experiment were to see if memory was affected 
negatively by BZP and if anxiety was also effected by BZP as has been shown previously. BZP 
did show some effects on memory especially in the higher BZP group. However there were 
other conflicting results suggesting more research is needed and these effects did not seem to 
last long term. In terms of anxiety results did not fully support the hypothesis of the experiment. 





housing and after animals were 100 days old. Conversely in the light dark box most anxiety 
effects were seen at PND 60 but only in enriched animals. Furthermore, no significant anxiety 
effects were seen in the open field, therefore with some support for the hypothesis and some 
against the hypothesis it is difficult to assign anxiety effects to BZP. 
The other aim of the experiment was to see if enrichment attenuated any negative 
effects that might be present such as reduced memory or increased anxiety. Enrichment did 
show some memory enhancing effects but not only on measures that had shown a dose effect. 
This was similar for all the apparatuses suggesting enrichment may not attenuate memory 
impairment or anxiogenic effects of BZP but it may improve others such as locomotion or base 
anxiety. Many of these effects also diminished past PND 100 suggesting they did not last long 
term. 
5.2 Secondary Effects 
Although not all effects specifically related to the aim of the experiment it is still 
important to mention them as they have been shown to mediate main effects. As shown in the 
previous results, enrichment decreased ambulation in transitions of the Y maze but only at PND 
60. Furthermore, most enrichment effects were on locomotion (Elliott & Grunberg, 2005). 
Differences between sexes showed in Y maze results. At both ages females transitioned more 
often thereby showing higher ambulation which has often been reported (Craft, Clark, Hart, & 
Pinckney, 2006). Females also showed fewer novel observations indicating more anxiety than 
males. This could explain why dose effects were mostly seen for females in this measure due 
to a greater effect of neophobia which can increase novelty-related emotional reactivity 
(Aitken, 1974). 
In the elevated plus maze, cage enrichment increased open arm observations indicating 





groups. For sex, females were observed more often in the open and closed-arm which further 
suggests that they were more ambulatory than males at both ages. This was emphasised in the 
60 day closed arm entries for the enriched group. It also supports previously mentioned results 
suggesting that enrichment decreases anxiety and can increase differences between dose 
groups. 
For the light dark box the only main effect of cage type was that enriched animals were 
in the light more often which suggests enrichment decreased anxiety and thus supports previous 
mentioned results for rats treated with saline and 10mg/kg BZP. This effect was not apparent 
at PND 100 which also suggests these effects did not last into later adulthood. In this apparatus 
females once again showed higher instances of locomotion as reflected in entries of the light 
and total entries at both time periods. This was especially significant for rats in the 20mg/kg 
group. Females further showed lower anxiety than males which was shown in light 
observations at PND 60 and a faster emergence latency at PND 100.  
Cage and sex also significantly interacted with each other suggesting that enrichment 
affected responses based on gender.  Although emergence latency did not show any main 
effects of sex or cage, an interaction effect showed that enrichment increased emergence 
latency for females at PND 60 and in standard cages females emerged faster than males. This 
indicates that enrichment may have increased anxiety. However it may be better explained by 
the locomotion-reducing effects of enrichment (Elliott & Grunberg, 2005). Additionally, for 
PND 100 males’ enrichment increased observations in the novel open arm suggesting for this 
group that anxiety was reduced.  However this was not seen in other results. 
 Lastly, enrichment did not produce any main effects for the open field which supports 
the small enrichment effects seen in this apparatus. However, for sex as previously mentioned 





for saline treated animals and 10mg/kg BZP (this was seen in both cage conditions) and fewer 
instances of immobility especially for 10mg BZP. Furthermore, males occupied the centre 
more often than females suggesting lower anxiety compared with females which is contrary to 
the light dark box results. Conversely at PND 100 females occupied the centre more often than 
males suggesting that after 100 days the apparatus was no longer novel and therefore less 
anxiogenic. It is difficult to explain why males no longer occupied the centre more often and 
instead occupied the corners more often which suggests that males developed higher anxiety 
over time. This should be investigated in further study. Furthermore, females eliminated fewer 
faecal boil than males which indicates again that males developed higher anxiety over time. 
Therefore, females showed higher amounts of ambulation and over time males showed higher 
anxiety.  
Even though cage type did not produce any main effects; interaction effects suggest for 
some measures sex may have been affected by enrichment. In ambulation measures, as 
previously mentioned males displayed less locomotion than females this was the same for both 
housing types. However, enrichment increased ambulation for females which is contrary to 
most enrichment effects on locomotor activity, though it has been seen before (Meunier & 
Fishcer, 1985).  Another interaction between sex and enrichment was for faecal boluses at PND 
60 even though this measure was not affected by sex or cage type. Females eliminated fewer 
faecal boluses when enriched and fewer compared to males in enriched conditions. This may 
have been due to enrichment creating a greater decrease in anxiety for females than males 
however this is still unable to be explained 
In conclusion for each type of apparatus there were differences between males and 
females especially in locomotor measures. There were some effects of cage condition per se, 





5.3 Relationship to past research 
There was no previous research on memory effects of BZP so results seen in this study 
are new. Anxiety effects however have been previously seen in an experiment by  Aitchison 
and Hughes, (2006). In that experiment between PND 45-55 10mg/kg BZP was administered 
to animals. They were then tested in the Y Maze, light dark box, social interaction test and 
open field between PND 72-95. In the Y maze BZP animals spent decreased time in and entered 
the novel arm less often than controls as well as making fewer entries of both arms suggesting 
greater anxiety due to aversion to the novel area (Aitken, 1974). In the light dark box, they took 
longer to emerge and in the open field they ambulated and reared less often which have also 
proven to measures of increased anxiety (Aitken, 1974). The social interaction test also 
produced fewer interactions, which again suggests increased anxiety, as rats who have 
increased anxiety have fewer interactions in novel environments (File & Hyde, 1978; Rex, 
Voigt, Gustedt, Beckett, & Fink, 2004) 
Compared to this experiment, results from this study were not as clear. This is because 
in the open field there were no clear anxiety effects. Compared to the light dark box results of 
this experiment seemed to indicate increased anxiety but only for enriched groups so the results 
were variable. Conversely results from the elevated plus and the Y maze showed similar 
anxiogenic effects of BZP. 
There are many reasons why there may have been different anxiety effects between 
these studies. Firstly, in this experiment BZP was administered from 41 days old to 51 instead 
of 45- 55. Therefore BZP administered in mid adolescence compared to later adolescence seen 
preciously may have affected different brain areas (Broadwater & Spear, 2013). Furthermore, 
in the experiment from PND 72-95 was when subjects were tested and in this experiment two 





used to represent early and mid-adulthood (Andersen, 2003). Because these two periods in 
which animals were tested were different from the previous experiment it may explain why 
conflicting results were found. Furthermore, enrichment was used in this experiment which 
was not used in the previous experiment this may have enhanced or decreased dose effects 
compared to saline. 
There have been no previous experiments investigating enrichment effects on negative 
memory and anxiety effects of BZP however there has been experiments considering 
environmental enrichment effects on memory and anxiety for other drugs. In an experiment by 
Wainwright et al. (1993) animals prenatally exposed to ethanol were tested in the Morris water 
maze when they were 10 weeks old. Animals had previously been separated into groups 
receiving different types of enrichment and no enrichment. In this maze enrichment decreased 
time taken to find the hidden platform over testing days and they spent increased time in the 
target area in a probe trial compared to non-enriched, indicating enrichment decreased ethanol 
induced anxiety.  
Results from this experiment were similar showing enrichment did improve spatial 
memory. Although this was not seen for all measures this may be because of the different drug 
and administration period used in that experiment. Furthermore, the experiment only 
investigated results after 10 weeks. In the current experiment, effects were investigated after a 
longer period (PND 100) as well as PND 60 results which is longer than what the 
aforementioned experiment investigated. Therefore, it is possible that enrichment may not 
continue to have memory enhancing effects after a PND 100. The type of apparatus was 






Lastly enrichment effects on BZP anxiety have not been previously investigated 
however enrichment effects on anxiety due to other drugs has been demonstrated previously.  
Hughes and Otto (2013) housed animals in enriched or standard caging for 4.5 months and 
before each of their trials in an open field, light dark box or Y maze 2mg/kg of scopolamine 
was injected into subjects. In the open field enrichment increased occupancy in the centre of 
the apparatus, and decreased time taken to emerge into the light of the light dark box. Increased 
entries into the light side of the apparatus was also observed. In the Y maze entries into and 
time spent in the novel arm increased for enriched subjects. These results therefore showed that 
enrichment reduced anxiety in this experiment. 
Results in this experiment were significantly different as they showed both increased 
and decreased anxiety. This is because enrichment did not show significant effects in the open 
field, however it did show similar anxiety reducing effects for the elevated plus maze. In the 
light dark box although environmentally enriched subjects showed differences from standard 
housed subjects it’s not clear whether the difference was due to an attenuation of BZP effects 
or other anxiety effects. The reason for these differences may be due to the longer exposure to 
enrichment before testing began and shorter period between drug administration and testing. 
In conclusion results from this experiment did show some similarities to previous 
studies. However, differences that have occurred may be due to differences in administration 
periods, testing periods, exposure to BZP and apparatus used to measure anxiety and memory 
responses. Furthermore, the inclusion of enrichment and sex as well as two different time 
periods may have affected the results in this study. 
5.4 Theoretical and practical implications  
One of the theoretical implications of this study is that neuronal imprinting may only 





were seen after PND 60 but not in later adulthood. This is a problem since neuronal imprinting 
theory posits that effects of the drug should only be revealed later in adulthood (Andersen & 
Navalta, 2004). However, for the elevated plus maze BZP effects were only shown after PND 
100 which supports neuronal imprinting theory. Therefore, this shows that neuronal imprinting 
may have some validity but only with the elevated plus maze. It is beyond the scope of this 
experiment to determine why this effect was only shown for this apparatus and needs 
investigating to be explained. 
Although this experiment showed mixed results it still has implications for adolescents. 
This is because shorter term memory effects have been suggested from these results which 
suggest that spatial memory may be impaired. For humans, this is significant because we use 
spatial memory to remember where we have left an object or the layout of a house (Shrager, 
Bayley, Bontempi, Hopkins, & Squire, 2007). Therefore, this has implications for not 
remembering where things were put at both the home and at work or school. It also suggests 
that BZP may affect the hippocampus in the shorter term (Shrager et al., 2007). 
The mixed anxiety results also have implications because it suggests BZP induced 
anxiety may reveal itself sooner in some people and later in others. Furthermore, because these 
results are mixed it suggests that anxiety may not always be an outcome of BZP use and is due 
to a combination of BZP as well as other factors. This is especially relevant as for humans 
using BZP in adolescence as a combination of factors such as sex and life experiences may 
lead to future anxiety not just BZP use alone (Donner & Lowry, 2013; Wittchen et al., 2011). 
However, because of the mixed results further research is still needed. 
Lastly it has implications for enrichment research as it shows additional research is 
needed to determine how much enrichment is needed to attenuate decreased memory or 





drugs as well as others and may inflate differences in effects which also needs to be 
investigated. Since environmental enrichment has attenuated some effects it is still important 
for teenagers. This is because if adolescents can perform cognitively enriching tasks or physical 
activity it could attenuate reduced memory or heightened anxiety effects caused by BZP. 
However, because enrichments effects were varied additional research is needed to determine 
whether this is something worth implementing. 
5.5 Methodological Strengths 
The first strength of this experiment was using rats as representations of human 
teenagers, because rats develop quicker than humans and therefore reach adulthood faster as 
well. This is important because it allows analysis of drug effects over a shorter period than 
would be used with humans. Furthermore, it allows controlled administration of a drug that 
would be illegal to administer in New Zealand. This is relevant because it would also be 
difficult to find subjects who were willing to admit using illicit substances regularly due to the 
illegality of taking the drug. Consequently, using rats instead of humans is an important 
strength of this research. 
 A second strength of this experiment was two different BZP doses were used. This is 
a strength because different doses of BZP may have produced different results, especially as 
some of the results of this research were only significant for certain doses of BZP. It also applies 
to humans because party pills that contain BZP can differ on the amount of BZP inside the pill 
(Cohen & Butler, 2011). 
A third strength of this research was the testing of animals after PND 60 and PND 100. 
This was important because it showed that some BZP effects may only be present in early 
adulthood and may not continue into later adulthood. It also allowed analysis of enrichment 





investigating long term effects. Furthermore, this was a strength because it allowed analysis of 
whether neuronal imprinting theory applied to BZP effects 
A final strength of this research was using environmental enrichment to determine 
whether enrichment can mediate BZP effects. This was an important strength because it 
allowed determination if any memory or anxiety effects that occurred could be ameliorated by 
enrichment. It also showed that some BZP effects were increased by enrichment allowing for 
future study opportunities. It also had applications for humans because it meant that some 
effects that were effected by enrichment could be ameliorated in humans as well using 
cognitively enriching tools with teenagers. 
In summary, there were many strengths to this experiment which allowed its results to 
be generalised to humans and thoroughly investigate long term BZP use. These included using 
an animal model of human responses to BZP, since this is commonly used and rats develop at 
a faster rate than humans. Furthermore, the application of two different BZP doses and age 
ranges allowed investigations of whether strength of dose plays a part and if effects continue 
into later adulthood. Lastly the use of enrichment procedures provided information about 
whether enrichment is a viable way of attenuating BZP effects and if it may emphasis 
differences between saline and BZP. These strengths provided further credibility to the results 
found in this experiment. 
5.6 Limitations 
There were some limitations of this study that are worth noting when considering the 
results produced. The first limitation was that the acute effects of the drug were not measured. 
This is an important limitation as information about BZP acute effects could have had relevance 
to the effects seen in this experiment. It could also be used to further research acute outcomes 





However, because this study was mostly focused on adulthood effects it is not a significant 
exclusion. 
A second limitation was that a neurochemical analysis of the rat’s brains was not 
performed after the experiment. This would have been important as it could have shown 
changes in dopamine which may have explained locomotor effects found in this experiment 
(Goodwin, Patel, Kenworthy, & Khoshbouei, 2010). Furthermore, differences between saline 
and BZP rats in 5-HT may have been found with these analyses which could have indicated 
anxiety (Padovan, 2013). This is important as changes in 5-HT and dopamine are caused by 
BZP consumption (Esa Meririnne, Miina Kajos, Aino Kankaanpaa, & Timo Seppala, 2006; 
Schep et al., 2011). Therefore, if a neurochemical analysis was performed it may have been 
easier to see BZP effects as represented by chemical changes. However, because behavioural 
measures were used any effects on anxiety and memory were still able to be studied so not 
having these analyses didn’t subtract from this thesis. 
A third limitation was that observer reliability tests were not used to ensure all 
observations the apparatus especially the open field were consistent. This is an important 
limitation because it is possible for an observer to be subconsciously seeing what they expect 
to see (Kaufman & Rosenthal, 2009). Furthermore, during the experiment results were recorded 
every 3 seconds and this fast pace recording may have led to mistakes in what was recorded 
(Kaufman & Rosenthal, 2009). Using another observer briefly to conduct inter-observer 
reliability examinations for a random portion of the data would have made sure that all results 
recorded were accurate (Kaufman & Rosenthal, 2009; Rosenthal, 1976). Therefore, it was a 
limitation to not include inter-observer testing to ensure results were accurate. However, having 
just one experimenter recording animal behaviour did allow consistency throughout the 





Lastly another limitation is that there were multiple extraneous variables within this 
experiment. Firstly, during parts of the experiment the room in which animals were being tested 
was being shared with another experimenter. Although this was due to limited room capacity 
it could have distracted the animals due to persons other than the experimenter being in the 
room and the smell of the experimenter’s other rats could have directed the subject attention 
elsewhere. Furthermore, due to sharing a room with other experimenters the time at which 
testing took place was varied throughout the day based on conflicting schedules. Therefore, 
sometimes rats were tested in the early afternoon and other times that were tested later at night. 
The change in timing of testing is an important issue as it can affect locomotion and anxiety 
responses (Kaya, Karakaş, & Coşkun, 2011; Keith et al., 2013; Popović et al., 2009). Therefore, 
extraneous variables related to the room in which animals were tested was a further limitation 
of this experiment. However, although these variables may have affected results they were not 
always present so they may not have had a significant impairment. Steps were also taken to 
minimise room noise from other experimenters and separate animals as far as possible to reduce 
these olfactory stimuli. 
In summary although acute effects were not measured this experiment was focused on 
adulthood responses so exclusion of this measure was not of high importance. Secondly 
although neurochemical analysis would have been useful it did not reduce importance of 
behavioural effects that were measured. Furthermore, although inter-observer reliability testing 
would have been useful to ensure results were accurately recorded, the same experimenter was 
used throughout the study which would have produced consistent results. Lastly extraneous 
variables may have affected results however they were minimised so that results are as accurate 







5.7 Future Directions  
For future research the limitations of this study need to be addressed. It would be 
advantageous to measure acute BZP effects to show the impact that different doses of BZP are 
having on the rats. Applying neurochemical techniques to look at differences between BZP 
treated and control animals to determine if the serotonergic signs of anxiety are present would 
also be needed in future research. This could also be used to look at neurochemical differences 
between enriched and standard caged animals. If this is used in future research it would also 
help explain conflicting results seen in this experiment. Using inter-observer measures to make 
sure results are being recorded accurately would also be advantageous as well as testing 
animals at the same time of day and testing animals in a room with fewer extraneous variables 
to allow consistency of results.  
Future research should also investigate the conflicting results seen for the 10mg/kg BZP 
group and why these occurred. This is because within the open field there were conflicting 
anxiety results for this group so it is important to investigate why this occurred. Furthermore, 
many BZP anxiety effects revealed in this study were only found in enriched caging and not 
standard caging. This needs to be considered in future research to see if enrichment may 
enhance differences between saline and other drugs.  
Results in the Y maze suggested that BZP may have a detrimental effect on memory in 
early adulthood. Therefore, investigation into whether these effects occur more prominently in 
other memory tasks such as the Morris water maze needs to be investigated. Anxiety effects 
although mixed depending on the apparatus need to be further investigated as there is still 
suggestion from these results that BZP is anxiogenic.  
Lastly enrichment effects were also varied in this experiment but that may have been 





completed to see if enrichment does have an effect under different conditions and with fewer 
extraneous variables. It may also be advantageous to see if enrichment has an effect with only 
one dose type to make comparisons simpler. 
Therefore, there are many future directions in which this research can be taken. Firstly, 
the limitations of this research can be improved upon to see if better results are obtained. 
Further research into whether memory effects seen in the Y maze at PND 60 are due to memory 
by using different apparatus would also be advantageous as well as investigating effects 
produced by 10mg/kg BZP. A continued investigation into the anxiety effects of BZP and 
possible amelioration also be considered in future research. 
5.8 Conclusions 
In conclusion, the aim of this experiment was to determine whether BZP use in 
adolescence has long term impact on memory and anxiety. It was also hypothesised that any 
effects that did occur would be ameliorated by environmental enrichment. This was 
hypothesised based on previous research which showed that adolescents are vulnerable to drug 
taking and that drug taking can influence the still developing brain (Lubman & Yücel, 2008). 
One of the drugs that adolescents could consume is BZP which is usually ingested in the form 
of party pills that are commonly taken by teenagers. Since research has shown that BZP may 
be addictive due to its chemical similarity to other amphetamines it is also possible adolescents 
may become addicted to this drug (Bava & Tapert, 2010). Therefore, it was important to 
investigate the adulthood effects of this drug especially since it has been posited that BZP may 
cause anxiety in adulthood BZP ( Aitchison & Hughes, 2006) . Furthermore, enrichment has 
been shown to ameliorate decreased memory and heightened anxiety effects which is why 
environmental enrichment was chosen to try to attenuate similar effects cause by BZP( 





To investigate the aims of this experiment enriched and standard caged subjects were 
treated over 10 days with either saline, 10mg/kg or 20mg/kg BZP after PND 41. Then at PND 
60 they were tested in four apparatus including the responsiveness to change Y maze, elevated 
plus maze, light dark box and open field. Approximately two days between testing in each 
apparatus was used so that animals didn’t acclimate to the apparatuses. They were then tested 
at PND 100 and there behaviours were recorded at each time. 
The results of this experiment were mixed with BZP showing a decrease in spatial 
memory capabilities in some measures and enrichment ameliorating some of these effects when 
sex was considered. In the elevated plus maze anxiety effects were shown but only after PND 
100 and these effects were not ameliorated by enrichment, although enrichment did show some 
effects after PND 60. In the light dark box anxiety was shown at both time periods however 
this was only shown in enriched conditions which suggests that anxiety differences may be 
brought out by enrichment. Enrichment did show an effect in this apparatus but because BZP 
was not significantly different from saline in standard cages this effect may not have been on 
BZP induced anxiety. In the open field anxiety effects were not clearly seen and enrichment 
had greater effects on locomotion.  
Therefore, results did show some support for anxiety induced by BZP, however this 
was only shown under certain conditions and in certain apparatus. Memory effects were also 
shown but only in the shorter term and not long term. Enrichment effects did attenuate some 
memory effects and some anxiety effects as expected but there were some conflicting results. 
Therefore, additional research is needed into these effects and whether with limitations 
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